A proprietary topical delivery technology that provides short-acting mucosal pain relief during placement of an intrauterine device (IUD). The product has additional potential applicability to a range of other important women’s health procedures.
Lidbree is approved for commercial use in Europe and will be further developed for future market introduction in the United States.